Published in Crit Care Clin on April 01, 2017
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol (2008) 9.25
Long-term cognitive impairment after critical illness. N Engl J Med (2013) 9.20
Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med (2013) 6.04
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med (2007) 5.65
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol (2006) 4.43
Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med (2010) 4.22
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Immunotherapy for sepsis--a new approach against an ancient foe. N Engl J Med (2010) 3.62
Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med (2005) 3.21
History of myeloid-derived suppressor cells. Nat Rev Cancer (2013) 3.14
CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clin Cancer Res (2013) 3.02
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med (2015) 2.81
Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am (1995) 2.59
Host resistance in sepsis and trauma. Ann Surg (1975) 2.56
Long-term survival of adult trauma patients. JAMA (2011) 2.55
Physical therapy for the critically ill in the ICU: a systematic review and meta-analysis. Crit Care Med (2013) 2.33
The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care (2005) 2.31
Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg (2012) 2.24
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med (2010) 2.17
Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med (1996) 2.10
Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg (2012) 2.07
A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med (2010) 2.06
Neutrophil mobilization and clearance in the bone marrow. Immunology (2008) 1.87
The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med (2008) 1.86
Multiple organ failure in polytrauma patients. J Trauma (1983) 1.81
Emergency granulopoiesis. Nat Rev Immunol (2014) 1.70
Arginine and immunity. J Nutr (2007) 1.62
Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol (2010) 1.56
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med (2015) 1.55
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr (2016) 1.50
Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg (1996) 1.41
Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care (2011) 1.40
Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur J Immunol (2009) 1.40
The systemic inflammatory response syndrome. Microbes Infect (2006) 1.31
Parallels between cancer and infectious disease. N Engl J Med (2014) 1.16
Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure. Shock (2003) 1.15
Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock (2007) 1.14
Strategies to improve drug development for sepsis. Nat Rev Drug Discov (2014) 1.14
Temporal trends of postinjury multiple-organ failure: still resource intensive, morbid, and lethal. J Trauma Acute Care Surg (2014) 1.11
Outcome predictors and quality of life of severe burn patients admitted to intensive care unit. Scand J Trauma Resusc Emerg Med (2010) 1.06
Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. J Crit Care (2013) 1.03
Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg (1992) 1.01
Timing and causes of death after injuries. Proc (Bayl Univ Med Cent) (2013) 0.98
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg (1994) 0.93
Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance. Front Immunol (2012) 0.90
Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection. J Leukoc Biol (2015) 0.86
Long-term survival after surgical intensive care unit admission: fifty percent die within 10 years. Ann Surg (2011) 0.84
Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock. Ann Surg (2016) 0.84
DAMPs activating innate immune responses in sepsis. Ageing Res Rev (2015) 0.83
Advances in immunotherapy for melanoma. BMC Med (2016) 0.83
DANGER IN THE INTENSIVE CARE UNIT: DAMPS IN CRITICALLY ILL PATIENTS. Shock (2016) 0.82
A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects. Shock (2010) 0.82
Early organ dysfunction affects long-term survival in acute pancreatitis patients. HPB (Oxford) (2014) 0.81
A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged. J Immunol (2015) 0.81
Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis. Blood Purif (1993) 0.80
Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia. Infect Immun (2014) 0.80
Resuscitation beyond the abdominal compartment syndrome. Curr Opin Crit Care (2010) 0.79
Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure. J Adv Nutr Hum Metab (2015) 0.78
Discovering the truth about life after discharge: Long-term trauma-related mortality. J Trauma Acute Care Surg (2016) 0.77
Diagnostic and prognostic value of myeloid-related protein complex 8/14 for sepsis. Am J Emerg Med (2015) 0.77